Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial
World Journal of Urology · 2024
DOI: 10.1007/s00345-024-04799-4 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift World Journal of Urology, 2024. Verfasst von Naoki Wada und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Renal and Urologic Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510, Japan. nwada@asahikawa-med.…. Hauptthemen laut MEDLINE: Urinary Bladder, Overactive, Urinary Incontinence, Urological Agents, Pyrimidinones. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Renal and Urologic Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510, Japan. nwada@asahikawa-med.ac.jp.
- Nagayama Renal and Urology Clinic, Asahikawa, Japan.
- Department of Renal and Urologic Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka Higashi, Asahikawa, 078-8510, Japan.
- Department of Urology, Kitasaito Hospital, Asahikawa, Japan.
- Department of Urology, Hokushinkai Megumino Hospital, Eniwa, Japan.
- Department of Urology, Fukagawa City Hospital, Fukagawa, Japan.
Zitieren
APA
Wada, N., Mizunaga, M., Abe, N., Miyauchi, K., Kobayashi, S., Ohtani, M., Tsunekawa, R., Nagabuchi, M., Morishita, S., Ohyama, T., Yamaguchi, S., Iuchi, H., Noda, T., Saga, Y., Motoya, T., Kawakami, N., Nishihara, M., Numata, A., & Kakizaki, H. (2024). Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial. World Journal of Urology. https://doi.org/10.1007/s00345-024-04799-4
Vancouver
Wada N, Mizunaga M, Abe N, Miyauchi K, Kobayashi S, Ohtani M, et al. Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial. World Journal of Urology. 2024. doi:10.1007/s00345-024-04799-4
BibTeX
@article{Wada2024,
author = {Wada, Naoki and Mizunaga, Mitsuhiro and Abe, Noriyuki and Miyauchi, Kotona and Kobayashi, Shin and Ohtani, Miyu and Tsunekawa, Ryoken and Nagabuchi, Masaya and Morishita, Shun and Ohyama, Teppei and Yamaguchi, Satoshi and Iuchi, Hiromichi and Noda, Tsuyoshi and Saga, Yuji and Motoya, Tadasu and Kawakami, Norihiro and Nishihara, Masayuki and Numata, Atsushi and Kakizaki, Hidehiro},
title = {Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter prospective randomized crossover trial},
journal = {World Journal of Urology},
year = {2024},
doi = {10.1007/s00345-024-04799-4}
}
EUVIMED